Startups
Nemesis Symbiotics© will make existing antibiotics work again, prevent the spread of resistance genes and so also protect the efficacy of new antibiotics.
Overview
Employees
1-10
Total raised
$3.22M
Founded date
2014
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 8, 2017 | Seed round | $905.88K | |
| Jun 16, 2015 | Seed round | $469.41K |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 5, 2018 | UK Innovation & Science Seed Fund Invests in Seven Companies | UK Innovation & Science Seed Fund (UKI2S) , formerly known as Rainbow Seed Fund, a Harwell, Oxford-based early-stage venture capital fund focused on promising technologies based on the UK’s publicly-funded research, has invested in seve... |
| May 8, 2017 | Nemesis Bioscience Raises over £700K in Seed Funding | Nemesis Bioscience, a Cambridge and Cardiff, UK-based developer of products to resurrect anti-microbial therapies made ineffective by increasing microbial resistance, raised over £700k in seed funding. The round was led by The Rainbow Seed ... |
| Jul 11, 2016 | Nemesis Bioscience appointS Dr Alastair Riddell as non-executive chairman | Nemesis Bioscience appointS Dr Alastair Riddell as non-executive chairman 11-07-2016 Nemesis Bioscience today announced the appointment of Dr Alastair Riddell as non-executive Chairman. The appointment, effective from 1st July, will bring A... |
| Aug 17, 2015 | Nemesis Bioscience receives Innovate UK Smart funding award | Nemesis Bioscience receives Innovate UK Smart funding award 17-08-2015 Nemesis Bioscience Ltd (Cambridge, UK) announced today that it has received a funding award from the UK’s innovation agency, Innovate UK. The Smart Award will be used to... |
| Jun 16, 2015 | Nemesis Bioscience raises £300,000 in seed funding and opens development facility in Wales | Nemesis Bioscience Ltd has raised £300,000 in seed funding from Angel investors and from Finance Wales to extend the application of its proprietary biological therapeutics – Nemesis Symbiotics that inactivate antibiotic resistance. They hav... |
| Jun 16, 2015 | Nemesis Bioscience raises £300,000 in seed funding and opens development facility in Wales | Nemesis Bioscience raises £300,000 in seed funding and opens development facility in Wales 16-06-2015 Nemesis Bioscience Ltd has raised £300,000 in seed funding from Angel investors and from Finance Wales to extend the application of its pr... |
Reviews 0
FAQ about Bacterial Cybergenetics
When was Bacterial Cybergenetics founded?
Bacterial Cybergenetics was founded in 2014.
How much funding has Bacterial Cybergenetics raised?
Bacterial Cybergenetics has raised $3.22M in total across 3 funding rounds.
What funding rounds has Bacterial Cybergenetics raised?
Parsers VC lists 3 funding rounds of Bacterial Cybergenetics, among them a seed round of $905.88K on May 8, 2017 and a seed round of $469.41K on Jun 16, 2015.
What has the press written about Bacterial Cybergenetics?
Parsers VC has collected 7 articles mentioning Bacterial Cybergenetics, among them “UK Innovation & Science Seed Fund Invests in Seven Companies” (Mar 5, 2018) and “Nemesis Bioscience Raises over £700K in Seed Funding” (May 8, 2017).
Is Bacterial Cybergenetics still active?
Yes, Bacterial Cybergenetics is active; its latest activity on Parsers VC dates from Jun 19, 2018.